Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset [PDF]
Kern J +12 more
europepmc +1 more source
Subacute Juvenile Sandhoff Disease: A Progressive Neurodegenerative Disorder. [PDF]
Kadam BD +3 more
europepmc +1 more source
Linking glycosphingolipid metabolism to disease-related changes in the plasma membrane proteome. [PDF]
Monkhouse H, Deane JE.
europepmc +1 more source
Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay-Sachs Disease. [PDF]
Guerrero-Vargas JM +6 more
europepmc +1 more source
Surrogate Biomarkers in Gene Therapy for Orphan Diseases: Validation, Application, and Regulatory Aspects. [PDF]
Ayupova AI +4 more
europepmc +1 more source
Increasing β-hexosaminidase A activity using genetically modified mesenchymal stem cells. [PDF]
Shaimardanova AA +10 more
europepmc +1 more source
CNS-targeted base editing of the major late-onset Tay-Sachs mutation alleviates disease in mice. [PDF]
Allende ML +12 more
europepmc +1 more source
Microglia-neuron crosstalk through Hex-GM2-MGL2 maintains brain homeostasis. [PDF]
Frosch M +21 more
europepmc +1 more source
Imaging manifestations in infantile GM1 gangliosidosis: a rare lysosomal storage disorder: a paediatric case report. [PDF]
Bhat S, Sharma S, Bhat S, Kaul A.
europepmc +1 more source

